Anushka Patel

Q: What Schools Are Affiliated With Anushka Patel

Anushka Patel is affiliated with the following schools: Charles Darwin University, University of Queensland, University of New South Wales, University of Sydney

Anushka Patel's AcademicInfluence.com Rankings

Anushka Patel

Philosophy

#7596

World Rank

#10832

Historical Rank

Logic

#4646

World Rank

#5964

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Anushka Patel Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Anushka Patel is Chief Executive Officer at The George Institute for Global health, a Professor of Medicine at the University of New South Wales, and Cardiologist at the Royal Prince Alfred Hospital.

(See a Problem?)

Anushka Patel's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. (2008) (5018)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial (2007) (1848)
Severe hypoglycemia and risks of vascular events and death. (2010) (1317)
Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. (2009) (850)
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (801)
Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. (2015) (627)
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. (2014) (503)
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data (2014) (449)
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) (423)
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. (2003) (382)
Task Shifting for Non-Communicable Disease Management in Low and Middle Income Countries – A Systematic Review (2014) (365)
Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial. (2013) (348)
Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes (2014) (322)
Risk prediction in patients with heart failure: a systematic review and analysis. (2014) (315)
Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes (2009) (265)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. (2013) (264)
Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. (2002) (263)
Lowering blood pressure reduces renal events in type 2 diabetes. (2009) (251)
Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis (2014) (231)
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials (2011) (203)
Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. (2009) (202)
The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis (2008) (199)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy (2009) (177)
Effects of Visit-to-Visit Variability in Systolic Blood Pressure on Macrovascular and Microvascular Complications in Patients With Type 2 Diabetes Mellitus: The ADVANCE Trial (2013) (177)
Patients with Type 2 Diabetes (2014) (170)
An International Randomised Placebo-Controlled Trial of a Four-Component Combination Pill (“Polypill”) in People with Raised Cardiovascular Risk (2011) (154)
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk (2015) (147)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (the AusHEART study) (2010) (145)
Effects of fibrates in kidney disease: a systematic review and meta-analysis. (2012) (141)
Study rationale and design of ADVANCE: Action in diabetes and vascular disease - Preterax and diamicron MR controlled evaluation (2001) (140)
Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study (2014) (137)
Event Rates, Hospital Utilization, and Costs Associated with Major Complications of Diabetes: A Multicountry Comparative Analysis (2010) (135)
Gaps in cardiovascular disease risk management in Australian general practice (2009) (127)
Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke (2005) (125)
Contemporary model for cardiovascular risk prediction in people with type 2 diabetes (2011) (123)
An Electronic Clinical Decision Support Tool to Assist Primary Care Providers in Cardiovascular Disease Risk Management: Development and Mixed Methods Evaluation (2009) (115)
Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. (2009) (114)
Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka: A Randomized Clinical Trial (2018) (109)
Prediction of kidney-related outcomes in patients with type 2 diabetes. (2012) (106)
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines (2020) (98)
Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries. (2016) (98)
SMARTHealth India: Development and Field Evaluation of a Mobile Clinical Decision Support System for Cardiovascular Diseases in Rural India (2014) (97)
Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy (2012) (93)
Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial (2015) (93)
Body mass index and risk of diabetes mellitus in the Asia-Pacific region. (2006) (93)
Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. (2010) (89)
Socio-economic distribution of cardiovascular risk factors and knowledge in rural India. (2012) (88)
Cardiovascular, respiratory, and related disorders: key messages from Disease Control Priorities, 3rd edition (2017) (86)
Epidemiology of Cardiovascular Disease in China and Opportunities for Improvement: JACC International. (2019) (82)
Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease (2005) (81)
The Efficacy and Tolerability of ‘Polypills’: Meta-Analysis of Randomised Controlled Trials (2012) (78)
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review (2017) (78)
Gender inequalities in cardiovascular risk factor assessment and management in primary healthcare (2017) (77)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes (2014) (75)
Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease. (2003) (74)
Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings: findings from the Kanyini Audit (2009) (72)
Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial (2013) (68)
ADVANCE—Action in Diabetes and Vascular Disease: patient recruitment and characteristics of the study population at baseline (2005) (66)
Cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in Indonesia: The SMARThealth Extend study (2019) (63)
Associations between high-density lipoprotein cholesterol and both stroke and coronary heart disease in the Asia Pacific region. (2007) (63)
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial (2010) (62)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
Increasing use of mental health services in remote areas using mobile technology: a pre–post evaluation of the SMART Mental Health project in rural India (2017) (59)
Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus (2012) (58)
Use of a Multidrug Pill In Reducing cardiovascular Events (UMPIRE): rationale and design of a randomised controlled trial of a cardiovascular preventive polypill-based strategy in India and Europe (2012) (56)
Effects of Combination of Perindopril, Indapamide, and Calcium Channel Blockers in Patients With Type 2 Diabetes Mellitus: Results From the Action in Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) Trial (2014) (55)
Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study). (2012) (54)
Smoking, diabetes and cardiovascular diseases in men in the Asia Pacific region (2009) (51)
Hospital Quality Improvement Initiative for Patients With Acute Coronary Syndromes in China: A Cluster Randomized, Controlled Trial (2014) (49)
Cholesterol, diabetes and major cardiovascular diseases in the Asia-Pacific region (2007) (47)
Retinal Vascular Lesions in Patients of Caucasian and Asian Origin With Type 2 Diabetes (2008) (45)
Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. (2005) (44)
Cultural Adaptations of Cognitive Behavioral Therapy. (2017) (44)
Prediction of Heart Failure by Amino Terminal-pro–B-Type Natriuretic Peptide and C-Reactive Protein in Subjects With Cerebrovascular Disease (2005) (44)
Managing the global burden of cardiovascular disease (2002) (43)
A multifaceted strategy using mobile technology to assist rural primary healthcare doctors and frontline health workers in cardiovascular disease risk management: protocol for the SMARTHealth India cluster randomised controlled trial (2013) (43)
The Treatment of cardiovascular Risk in Primary care using Electronic Decision suppOrt (TORPEDO) study: intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare (2012) (42)
System Barriers to the Evidence-Based Care of Acute Coronary Syndrome Patients in China: Qualitative Analysis (2014) (42)
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial (2021) (41)
Soluble vascular cell adhesion molecule 1 and N-terminal pro-B-type natriuretic peptide in predicting ischemic stroke in patients with cerebrovascular disease. (2006) (41)
Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials. (2019) (41)
Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk (2010) (41)
Body mass index is an independent determinant of left atrial size. (2008) (41)
Process evaluation of the systematic medical appraisal, referral and treatment (SMART) mental health project in rural India (2017) (38)
Efficacy and Safety of Quarter-Dose Blood Pressure–Lowering Agents: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2017) (38)
The Systematic Medical Appraisal, Referral and Treatment (SMART) Mental Health Project: Development and Testing of Electronic Decision Support System and Formative Research to Understand Perceptions about Mental Health in Rural India (2016) (37)
Association of Multifaceted Mobile Technology-Enabled Primary Care Intervention With Cardiovascular Disease Risk Management in Rural Indonesia. (2019) (36)
SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India (2019) (35)
Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials (2018) (35)
Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy: a systematic review and meta-analysis of randomized controlled trials. (2019) (34)
mHealth Interventions for Health System Strengthening in China: A Systematic Review (2017) (33)
Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World? (2011) (33)
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration. (2013) (32)
Absence of Peripheral Pulses and Risk of Major Vascular Outcomes in Patients With Type 2 Diabetes (2016) (31)
A randomised trial of the effects of an additional communication strategy on recruitment into a large-scale, multi-centre trial. (2007) (31)
Assessing the evidence–practice gap for heart failure in China: the Heart Failure Registry of Patient Outcomes (HERO) study design and baseline characteristics (2019) (29)
Comparison of Near-Patient Capillary Glucose Measurement and a Risk Assessment Questionnaire in Screening for Type 2 Diabetes in a High-Risk Population in Rural India (2011) (29)
Effects of blood pressure lowering on cardiovascular outcomes in different cardiovascular risk groups among participants with type 2 diabetes. (2012) (29)
Elevated total cholesterol: its prevalence and population attributable fraction for mortality from coronary heart disease and ischaemic stroke in the Asia-Pacific region (2008) (29)
Cardiovascular outcomes in type 2 diabetes: the impact of preventative therapies (2010) (29)
Blood Pressure Lowering in Type 2 Diabetes A Systematic Review andMeta-analysis (2015) (28)
Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial. (2019) (27)
What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study (2011) (27)
Risk Prediction in Patients With Heart Failure (27)
Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. (2015) (25)
Gender disparities in the assessment and management of cardiovascular risk in primary care: the AusHEART study (2011) (24)
Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk (2014) (24)
The NASSS framework for ex post theorisation of technology-supported change in healthcare: worked example of the TORPEDO programme (2019) (24)
Epidemiology of Sudden Cardiac Death in Rural South India - Insights From The Andhra Pradesh Rural Health Initiative (2011) (23)
Patients’ and Providers’ Perspectives of a Polypill Strategy to Improve Cardiovascular Prevention in Australian Primary Health Care: A Qualitative Study Set Within a Pragmatic Randomized, Controlled Trial (2015) (23)
Disparities between Prescribing of Secondary Prevention Therapies for Stroke and Coronary Artery Disease in General Practice (2012) (22)
The Effect of a Cardiovascular Polypill Strategy on Pill Burden. (2015) (22)
ADVANCE: breaking new ground in type 2 diabetes (2006) (22)
Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region? (2005) (22)
Relation Between Parent Symptomatology and Youth Problems: Multiple Mediation Through Family Income and Parent–Youth Stress (2015) (21)
Influence of cardiovascular absolute risk assessment on prescribing of antihypertensive and lipid-lowering medications: a cluster randomized controlled trial. (2014) (20)
Patient Preferences for a Polypill for the Prevention of Cardiovascular Diseases (2015) (19)
Global randomized trials: the promise of India and China. (2012) (19)
Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes (2017) (18)
Rationale and design of the AdRem study: evaluating the effects of blood pressure lowering and intensive glucose control on vascular retinal disorders in patients with type 2 diabetes mellitus. (2007) (18)
Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial. (2019) (18)
Validation of a general practice audit and data extraction tool. (2013) (17)
New tools for an old trade: a socio-technical appraisal of how electronic decision support is used by primary care practitioners. (2011) (17)
Atrial Fibrillation Screen, Management, and Guideline‐Recommended Therapy in the Rural Primary Care Setting: A Cross‐Sectional Study and Cost‐Effectiveness Analysis of eHealth Tools to Support All Stages of Screening (2020) (17)
Comparability of Patient-reported Health Status: Multicountry Analysis of EQ-5D Responses in Patients With Type 2 Diabetes (2011) (17)
Reanalysis of the Crystalloid versus Hydroxyethyl Starch Trial (CHEST). (2017) (17)
The Systematic Medical Appraisal Referral and Treatment Mental Health Project: Quasi-Experimental Study to Evaluate a Technology-Enabled Mental Health Services Delivery Model Implemented in Rural India (2020) (17)
Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiative. (2010) (17)
An economic case for a cardiovascular polypill? A cost analysis of the Kanyini GAP trial (2014) (17)
Coronary risk prediction for those with and without diabetes. (2006) (16)
Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease (2015) (16)
Women's cardiovascular health in India (2012) (16)
Predicting In-Hospital Mortality in Patients With Acute Coronary Syndrome in China. (2017) (16)
Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial. (2018) (16)
Psychological treatments for depression among women experiencing intimate partner violence: findings from a randomized controlled trial for behavioral activation in Goa, India (2019) (16)
Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit. (2008) (15)
The underutilisation of dual antiplatelet therapy in acute coronary syndrome. (2017) (15)
Cost‐effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial‐based analysis (2010) (15)
Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease (2016) (15)
Common mental disorders and risk factors in rural India: baseline data from the SMART mental health project (2018) (15)
What drives adoption of a computerised, multifaceted quality improvement intervention for cardiovascular disease management in primary healthcare settings? A mixed methods analysis using normalisation process theory (2018) (15)
A multifaceted quality improvement intervention for CVD risk management in Australian primary healthcare: a protocol for a process evaluation (2014) (15)
Reality and Truth: Balancing the Hope and the Hype of Real-World Evidence (2017) (14)
Sedentary Behavior and the Risk of Depression in Patients With Acute Coronary Syndromes. (2018) (14)
Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India (2018) (14)
Association of Low-Dose Triple Combination Therapy With Therapeutic Inertia and Prescribing Patterns in Patients With Hypertension: A Secondary Analysis of the TRIUMPH Trial. (2020) (13)
Prevention of cardiovascular disease in a rural region of India and strategies to address the unmet need (2011) (13)
Atrial Fibrillation Screen, Management And Guideline Recommended Therapy (AF SMART II) in the rural primary care setting: an implementation study protocol (2018) (13)
Systematic medical assessment, referral and treatment for diabetes care in China using lay family health promoters: protocol for the SMARTDiabetes cluster randomised controlled trial (2015) (13)
Intensive glucose control in type 2 diabetes – Reply (2008) (13)
Industry-sponsored clinical trials in emerging markets: time to review the terms of engagement. (2013) (13)
Two decades of research on innovative models of care delivery for patients with heart failure: the end or just the beginning? (2012) (13)
TRIple pill vs Usual care Management for Patients with mild-to-moderate Hypertension (TRIUMPH): Study protocol. (2014) (13)
Impact of Prior Use of Four Preventive Medications on Outcomes in Patients Hospitalized for Acute Coronary Syndrome--Results from CPACS-2 Study (2016) (12)
The HRT furore: getting the message right (2002) (11)
Implementing cardiovascular disease preventive care guidelines in general practice: an opportunity missed (2020) (11)
Facilitators and barriers to implementation of a pragmatic clinical trial in Aboriginal health services (2015) (11)
Acupuncture for blood pressure lowering: needling the truth. (2007) (11)
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence (2008) (11)
Opinions of community pharmacists on the value of a cardiovascular polypill as a means of improving medication compliance (2012) (11)
Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program (2017) (11)
Does Glycemic Control Offer Similar Benefits Among PatientsWith Diabetes in Different Regions of theWorld? Results from the ADVANCE trial (2011) (11)
Use of cardiovascular prevention treatments after acute coronary syndrome in China and associated factors. (2017) (10)
Use of major surgery in south India: A retrospective audit of hospital claim data from a large, community health insurance program. (2015) (10)
How Important Is Diabetes as a Risk Factor for Cardiovascular and Other Diseases in Older Adults? (2006) (10)
An integrated general practice and pharmacy-based intervention to promote the use of appropriate preventive medications among individuals at high cardiovascular disease risk: protocol for a cluster randomized controlled trial (2015) (10)
Study protocol: systematic review of the burden of heart failure in low- and middle-income countries (2012) (10)
ADVANCES IN REDUCING THE BURDEN OF VASCULAR DISEASE IN TYPE 2 DIABETES (2008) (10)
Implementing Kanyini GAP, a pragmatic randomised controlled trial in Australia: findings from a qualitative study (2015) (10)
An integrated community and primary healthcare worker intervention to reduce stigma and improve management of common mental disorders in rural India: protocol for the SMART Mental Health programme (2021) (9)
Implementation Strategies for Cardiovascular Polypills. (2019) (9)
SMART Mental Health Project: process evaluation to understand the barriers and facilitators for implementation of multifaceted intervention in rural India (2021) (9)
Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease (2007) (9)
Serum lipid levels and the prevalence of dyslipidaemia among rural and urban Thai adults--are the NCEP III guidelines appropriate? (2005) (8)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide in individuals with cerebrovascular disease (2007) (8)
Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints (2016) (8)
INterpreting the Processes of the UMPIRE Trial (INPUT): protocol for a qualitative process evaluation study of a fixed-dose combination (FDC) strategy to improve adherence to cardiovascular medications (2013) (8)
Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative (2017) (8)
Ethical standards for telemental health must be maintained during the COVID-19 pandemic (2020) (8)
The Benefit of Interventions to Reduce Posttraumatic Stress in Youth Exposed to Mass Trauma: A Review and Meta-Analysis (2019) (7)
ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes. (2006) (7)
The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes Mellitus (2014) (7)
Structural validation of The Patient Health Questionnaire-9 (PHQ-9) among Filipina and Indonesian female migrant domestic workers in Macao STRUCTURAL VALIDATION OF PHQ-9 (2020) (7)
Impact of Sustained Use of a Multifaceted Computerized Quality Improvement Intervention for Cardiovascular Disease Management in Australian Primary Health Care (2017) (7)
Blood Pressure Lowering In Diabetes: A Brief Review Of The Current Evidence And Description Of A New Trial (2001) (6)
Study protocol for a randomized controlled trial: the feasibility and impact of cardiovascular absolute risk assessment in Australian general practice. (2009) (6)
Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study. (2019) (6)
New insights from ADVANCE (2007) (6)
Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol (2020) (6)
Healthcare expenditure on Indigenous and non-Indigenous Australians at high risk of cardiovascular disease (2017) (6)
The ‘polypill’ in the prevention of cardiovascular disease (2014) (6)
Trials of cardiovascular risk factor management in type 2 diabetes (2009) (6)
Eff ects of fi brates on cardiovascular outcomes: a systematic review and meta-analysis (2010) (6)
A computer‐guided quality improvement tool for primary health care: cost‐effectiveness analysis based on TORPEDO trial data (2020) (6)
Gender-based violence and suicidal ideation among Indian women from slums: An examination of direct and indirect effects of depression, anxiety, and PTSD symptoms. (2021) (5)
Guideline for the diagnosis and management of hypertension in adults — 2016 (2017) (5)
The ADVANCE trial – Authors' reply (2008) (5)
Lifestyle intervention programme for Indian women with history of gestational diabetes mellitus (2019) (5)
Utilisation of Medicare-funded schemes for people with cardiovascular disease. (2017) (5)
Cholestrol, coronary heart disease, and stroke in the Asia Pacific region (2007) (2007) (5)
Treatment and outcomes of acute coronary syndromes in women: An analysis of a multicenter quality improvement Chinese study. (2017) (5)
Effects of a Lifestyle Intervention to Prevent Deterioration in Glycemic Status Among South Asian Women With Recent Gestational Diabetes (2022) (5)
EMPOWER: Toward the Global Dissemination of Psychosocial Interventions. (2022) (5)
Culturally Sensitive CBT for Refugees: Key Dimensions (2018) (5)
A pilot study adapting and validating the Harvard Trauma Questionnaire (HTQ) and PTSD checklist-5 (PCL-5) with Indian women from slums reporting gender-based violence (2022) (4)
System Barriers to the Evidence-Based Care of Acute Coronary Syndrome (ACS) Patients in China: A Qualitative Analysis (2011) (4)
Renoprotection with perindopril-indapamide below current recommended blood pressure targets in patients with type 2 diabetes mellitus: results of the ADVANCE trial (2008) (4)
Prescription of statins at discharge and 1‐year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL‐cholesterol in clinical pathways for acute coronary syndromes studies (2018) (4)
The post hoc use of randomised controlled trials to explore drug associated cancer outcomes: methodological challenges. (2013) (4)
Combatting the Global Crisis of Cardiovascular Disease. (2019) (4)
High prevalence of chronic kidney disease in (2008) (4)
Major surgery in south India: a retrospective audit of hospital claim data from a large community health insurance programme (2015) (4)
Effects of intensive blood glucose control on vascular outcomes in patients with type 2 diabetes (2009) (4)
Association of renal insufficiency with treatments and outcomes in patients with acute coronary syndrome in China. (2020) (4)
A global view of cardiovascular risk factors (2007) (3)
I-CARE randomized clinical trial integrating depression and acute coronary syndrome care in low-resource hospitals in China: Design and rationale. (2018) (3)
Developing and Evaluating mHealth Solutions for Chronic Disease Prevention in Primary Care: A Global Health Perspective (2019) (3)
Relation of time to treatment on relative effects of primary coronary angioplasty vs thrombolytic therapy (2000) (3)
An electronic decision support‐based complex intervention to improve management of cardiovascular risk in primary health care: a cluster randomised trial (INTEGRATE) (2021) (3)
Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset. (2017) (3)
Polypill (fixed-dose combination) in the prevention of cardiovascular disease: rationale and clinical data (2012) (3)
Retinal vascular lesions in patients with type 2 diabetes mellitus of Caucasian and Asian origin - baseline results from the AdRem study (2007) (3)
The role of the 12-lead ECG as a screening test for cardiac source of embolus. (2005) (3)
Prevention of vascular outcomes in type 2 diabetes: benefits of intensive blood pressure and blood glucose control with Preterax and Diamicron MR, Issue III (2008) (3)
Cost-effectiveness of a mobile technology-enabled primary care intervention for cardiovascular disease risk management in rural Indonesia. (2021) (3)
Polypills - A Central Strategy for Improving Cardiovascular Health. (2021) (3)
Understanding the impact of a multifaceted quality improvement intervention to improve cardiovascular disease risk management in Australian Primary Health Care: the TORPEDO study process evaluation [poster presentation] (2014) (3)
Relation Between Parent Symptomatology and Youth Problems: Multiple Mediation Through Family Income and Parent–Youth Stress (2014) (3)
Feasibility of a Lifestyle Intervention Program for Prevention of Diabetes Among Women With Prior Gestational Diabetes Mellitus (LIVING Study) in South Asia: A Formative Research Study (2020) (3)
Prevalence of dysglycaemia in rural Andhra Pradesh: 2005, 2010, and 2014 (2016) (3)
Intensive blood glucose control in diabetes – ADVANCE (2008) (2)
Use of Secondary Prevention Medications in Patients Following Admission with Acute Coronary Syndrome in Australia—The CONCORDANCE Study (2012) (2)
INTegrated Electronic General practice support tool, phaRmacy led intervention And combination Therapy Evaluation trial (INTEGRATE). (2015) (2)
Cost-effectiveness of blood pressure lowering with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: A trial-based analysis using the advance study (2010) (2)
Association of Low-Dose Triple Combination Therapy vs Usual Care With Time at Target Blood Pressure: A Secondary Analysis of the TRIUMPH Randomized Clinical Trial. (2022) (2)
Innovations in Community-Based Health Care for Cardiometabolic and Respiratory Diseases (2017) (2)
Gender Inequalities in Cardiovascular Disease Prevention and Management in Australian Primary Health Care: Results from the TORPEDO Study (2016) (2)
Heart Failure Therapies for the Prevention of HER2-Monoclonal Antibody-Mediated Cardiotoxicity: A Systematic Review and Meta-Analysis of Randomized Trials (2021) (2)
Associations Between Education Level and In-hospital Treatment and Outcomes Among Acute Coronary Syndrome in China. (2020) (2)
Impact of polypill based therapy on SBP and LDL cholesterol control stratified by potency of baseline regimen (2015) (2)
THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA (2009) (2)
Testing for Differences in the Reporting of Somatic Symptoms of Depression in Racial/Ethnic Minorities (2021) (2)
Progress in Medicine: Experts Take Stock (2015) (2)
Beyond the DSM-5 Diagnoses: A Cross-Cultural Approach to Assessing Trauma Reactions. (2021) (2)
Frontiers of Cardiovascular Polypills: From Atherosclerosis and Beyond. (2021) (1)
Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of evidence available in 2007 (2008) (1)
Cardiovascular risk in Type 2 diabetes – reflecting on the ADVANCE study (2009) (1)
Effects of glucose and blood pressure reduction on subclinical cardiac damage: Results from ADVANCE. (2022) (1)
New approaches for the prevention of vascular disease in Type 2 diabetes (2008) (1)
The relationship between total cholesterol and the risk of major cardiovascular diseases is similar amongst individuals with and without diabetes across populations in the Asia Pacific region (2007) (1)
Protocol for process evaluation of SMART Mental Health cluster randomised control trial: an intervention for management of common mental disorders in India (2022) (1)
Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial (2012) (1)
Framingham and UKPDS equations overestimate the risk of coronary events in a contemporary diabetic population (2009) (1)
THE IMPACT OF CIGARETTE SMOKING ON CARDIOVASCULAR DISEASE AMONGST WOMEN AND MEN IN THE ASIA-PACIFIC REGION (2005) (1)
Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial (2009) (1)
Management of cardiovascular risk factors in Australian General Practice of those at highest risk (2009) (1)
1047-179 Serum triglycerides and the risk of cardiovascular disease in the Asia pacific region: An individual participant data meta-analysis of cohort studies including 96,130 individuals (2004) (1)
A PRAGMATIC TRIAL OF A POLYPILL-BASED STRATEGY TO IMPROVE ADHERENCE TO INDICATED PREVENTIVE TREATMENTS AMONG PEOPLE AT HIGH CARDIOVASCULAR DISEASE RISK (2013) (1)
A randomised trial of the effects of an intensive communication strategy on recruitment into a large-scale, multi-centre trial (2007) (2007) (1)
“I put a stone on my heart and kept going”: An explanatory model of how distress is generated and regulated among Indian women from slums reporting gender-based violence (2021) (1)
Perindopril-based blood pressure-lowering therapy reduces amino-terminal-pro-B-type natriuretic peptide levels in subjects with cerebrovascular disease (2006) (1)
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP): a risk factor for most seasons (2005) (1)
Cardiovascular risk management among female and male patients in Australian General Practice: the AusHEART study (2009) (1)
O105 Effect Of A Multi-Faceted Quality Improvement Intervention To Improve Cardiovascular Disease Risk Identification And Management In Australian Primary Health Care: The Torpedo Cluster-Randomised Trial (2014) (1)
Lowering blood pressure in patients with diabetes--reply. (2015) (1)
Chronic kidney disease and the outcomes of fibrinolysis for ST-segment elevation myocardial infarction: A real-world study (2021) (1)
The APCSC Collaboration. The effects of diabetes melitus on the risks of major cardiovascular diseases and detath in the Asia-Pacific region (2002) (1)
PW203 Impact of pill burden on the effects of a polypill-based strategy on use of indicated medications in people with or at high risk of cardiovascular disease (2014) (1)
Cardiovascular risk: who should we treat, and how much should we stratify? (2009) (1)
Short-Term Changes in Serum Potassium and the Risk of Subsequent Vascular Events and Mortality (2022) (1)
A qualitative evaluation of a simplified cardiovascular management program in Tibet, China (2018) (1)
Blood pressure and lipid management in Australian General Practice – are guidelines being implemented? (2007) (1)
Lifestyle InterVention IN Gestational diabetes (LIVING) in India, Bangladesh and Sri Lanka: protocol for process evaluation of a randomised controlled trial (2020) (1)
Association between influenza vaccination, all-cause mortality and cardiovascular mortality: a protocol for a living systematic review and prospective meta-analysis (2021) (1)
HealthTracker: does electronic decision support improve identification and management of cardiovascular risk in Australian primary health care (2012) (1)
The Effects of a Lifestyle Intervention to Prevent Deterioration in Glycaemic Status Among South Asian Women with Recent Gestational Diabetes Mellitus: A Randomised Control Trial (2021) (1)
Process evaluation of a randomised controlled trial of a pharmacological strategy to improve hypertension control: protocol for a qualitative study (2018) (1)
Erratum: Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the action in diabetes and vascular disease: preterax and diamicron controlled evaluation (ADVANCE) trial (Hypertension (2014) 63 (259-264)) DOI: 10.1161/H (2015) (1)
Polypills for the prevention of cardiovascular disease: a framework for wider use (2022) (1)
Reduced efficacy of blood pressure lowering drugs in the presence of diabetes mellitus—results from the TRIUMPH randomised controlled trial (2022) (1)
Transient global amnesia as a complication of coronary angiography and angioplasty (2005) (0)
PS 14-28 EFFICACY AND SAFETY OF COMBINATION OF THREE OR MORE BP LOWERING DRUGS FOR THE MANAGEMENT OF HIGH BLOOD PRESSURE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (2016) (0)
Absolute cardiovascular risk assessment (workshop) (2004) (0)
GW27-e0874 The impact of prior use of four preventive medications on outcomes in patients hospitalized for acute coronary syndrome--Results from CPACS-2 Study (2016) (0)
Management of acute coronary events in China - preliminary results of a prospective survey (2005) (0)
Interpreting the Processes of the UMPIRE Trial (INPUT): the design of a process evaluation of a fixed dose combination (FDC) strategy to improve adherence to cardiovascular medications – a qualitative study. (2013) (0)
Abstract 13812: The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
Global Trends in Healthcare Delivery (plenary). (2016) (0)
Rationale for the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE) (2011) (0)
Perindopril protection against recurrent stroke study (PROGRESS) - new data on cardiac outcomes. Recent clinical trials update session (2002) (0)
Globalisation and heart failure in the 21st Century [plenary speaker]. (2014) (0)
Role of polypills in primary prevention of CVD (2015) (0)
ACS management - lessons learnt from developing countries (2005) (0)
What is the optimal target for glucose control in patients with increased cardiovascular risk [Plenary] (2017) (0)
Effect of blood pressure management on coronary heart disease in patients with type 2 diabetes mellitus. (2015) (0)
Innovation in Healthcare (keynote plenary) (2017) (0)
Improving Cardiovascular Health in Diverse Populations: A Conversation With Anushka Patel, MBBS, SM, PhD. (2017) (0)
Impact of cardiovascular polypill based therapy on healthy lifestyle behaviour (2015) (0)
What clinical trials do we need in diabetes (2008) (0)
Inflammatory markers and the risk of vascular complications and mortality in type 2 diabetes mellitus (2013) (0)
Cholesterol, stroke and coronary heart disease: evidence from 352,033 subjects in Asian and Pacific countries (2003) (0)
045 Atrial Fibrillation Screen, Management and Guideline Recommended Therapy (AF SMART II) in the Rural Primary Care Setting: Cost-Effective eHealth Tools to Support all Stages of Screening (2020) (0)
Why is there more heat than light concerning the polypill? (2008) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (Letter to the Editor) (2009) (0)
Management of chronic kidney disease in Australian general practice (the AusHEART Study) (2010) (0)
Current prescribing of Blood Pressure lowering and statin therapies in Australian general practice according to risk level using new guidelines for cardiovascular risk assessment (2009) (0)
[Plenary Session] Predicting risk in diabetes (2008) (0)
Inflammatory Biomarker Levels and The Risk of Vascular Complications and Mortality in Type 2 Diabetes Mellitus (2013) (0)
Risk factors for stroke in the Asia Pacific region (2003) (0)
Assessing and delivering cardiovascular health care in Asia (2008) (0)
Erratum. The Relationship Between Alcohol Consumption and Vascular Complications and Mortality in Individuals With Type 2 Diabetes. Diabetes Care 2014;37:1353–1359 (2015) (0)
Thrombolysis versus percutaneous coronary intervention for acute myocardial infarction – what do the meta-analyses tell us? (plenary) (2004) (0)
What do clinicians need to know about cardiovascular risk (2005) (0)
Panel on Global Health Trends [invited presentation]. (2016) (0)
Randomised clinical trials 101 – study power and principles of analysis [Invited speaker at a clinical trials symposium] (2011) (0)
Cardiovascular risk assessment (2005) (0)
[Review] Trials of cardiovascular risk management in diabetes (2009) (0)
Progress in reducing vascular disease in high risk patients (2003) (0)
Polypill: what will be its impact on cardiovascular disease prevention (2006) (0)
HDL Cholesterol is a Risk Factor for Diabetic Nephropathy But Not Retinopathy—Results From the ADVANCE Study (2011) (0)
A novel electronic decision support system to assist General Practitioners in cardiovascular disease risk management—A pilot evaluation (2009) (0)
Abstract 16361: Effects of Low-dose Triple Combination Therapy on Time at Target Blood Pressure - Results From the TRIUMPH Randomized Controlled Trial (2020) (0)
Collaborations to enhance chronic disease research capacity (2011) (0)
Digital technology – a 21st century response to attacks on aid and health care workers in conflict zones (roundtable) (2017) (0)
Prescribing of secondary prevention measures in Australian General Practice is lower in patients following an ischaemic stroke compared to those with a previous myocardial infarction (August 2009) (2009) (0)
[Plenary lecture] Hypertension – what’s in a name? (2008) (0)
Blood pressure and vascular complications of diabetes (2001) (0)
Cardiovascular risk in Australians and Indians: lessons from comparative studies (2009) (0)
Early definition of treatment outcomes after reperfusion therapy for myocardial infarction. (2004) (0)
Creating a new investment pool for innovative health systems research. (2017) (0)
Vascular risk factors: lessons and unanswered questions (2006) (0)
What’s happened to the polypill? (symposium) (2017) (0)
The identification and management of chronic kidney disease (CKD) and risk factors in aboriginal primary health care (2008) (0)
Results of principal endpoint studies, ongoing studies and expected future results (2002) (0)
SEDENTARY LIFESTYLE AND THE RISK OF DEPRESSION IN PATIENTS WITH ACUTE CORONARY SYNDROMES (2018) (0)
Cardiovascular risk perception and evidence–practice gaps in Australian general practice (2010) (0)
Prevention of cardiovascular disease in type 2 diabetes : Design, recruitment and characteristics of 11,140 patients in the ADVANCE study (2004) (0)
Health management and policy aspects of cardiovascular diseases [Invited speaker] (2013) (0)
Stepped wedge cluster randomised trials (clinical trials symposium). (2011) (0)
Clinical trials in primary care – opportunities and challenges. Clinical Trials Symposium (2006) (0)
Advances in the epidemiology and treatment of diabetes (2002) (0)
Management of patients with acute coronary syndromes in China (2006) (0)
[Letter to the Editor] ADVANCE Blood pressure lowering in diabetes (2009) (0)
[Plenary lecture] Intensive glucose control in patients with type 2 diabetes – the results of the ADVANCE trial in context (2008) (0)
Effects of visit-to-visit blood pressure variability on macrovascular and microvascular events in patients with type 2 diabetes: the ADVANCE trial (2012) (0)
Is all hypertension created equal (2005) (0)
Barriers to research (breakfast session) (2011) (0)
Improving the prognosis of patients with type 2 diabetes – what does the ADVANCE study tell us? (2007) (0)
Heart disease in women – are we treating it properly? (2008) (0)
ADVANCE – results of the blood pressure arm (2007) (0)
Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial (2008) (0)
Impact of glucose control on macrovascular and microvascular disease: insights from ADVANCE (2009) (0)
Efficacy and Safety of Low-Dose Triple and Quadruple Combination Pills vs Monotherapy, Usual Care, or Placebo for the Initial Management of Hypertension: A Systematic Review and Meta-analysis. (2023) (0)
[Plenary lecture] Blood glucose lowering in diabetes – ADVANCE vs. ACCORD (2008) (0)
Protection against cardiovascular and renal disease in type 2 diabetes: ADVANCEs in the control of blood pressure using Preterax and Diamicron MR. (2010) (0)
[Symposium] Trials of the cardiovascular polypill (2010) (0)
The development and feasibility of a composite score of echocardiographic indices that may stratify outcome in patients with diabetes mellitus. (2015) (0)
Routine blood pressure lowering and kidney disease in type 2 diabetes (2009) (0)
Blood glucose lowering and risks of vascular disease in type 2 diabetes (2007) (0)
Optimising TRIUMPH with 6·25 mg chlorthalidone - Authors' reply. (2020) (0)
Influential Factors of Medication Adherence in the HIV-Positive African-American Female Population (2017) (0)
Lifestyle factors, addiction and CVD risk - lessons from INTERHEART (2007) (0)
Global to Local (2017) (0)
Common trial problems - no pilot study, no treatment difference, and no adjustment for non-compliance. Clinical Trials Symposium (2005) (0)
The Systematic Medical Appraisal Referral and Treatment Mental Health Project: Quasi-Experimental Study to Evaluate a Technology-Enabled Mental Health Services Delivery Model Implemented in Rural India (Preprint) (2019) (0)
Mixed-Method Investigations Uncovering Tension, PTSD Symptoms, and Trauma-Related Difficulties Among Indian Women from Slums Reporting Gender-Based Violence (2022) (0)
Gender Differences in Survival and Readmission Following Acute Coronary Syndrome in China (2016) (0)
Anushka Patel- Carleton College (2012) (0)
Common trial problems – no pilot study, no treatment difference, and no adjustment for non-compliance (symposium) (2005) (0)
Adaptation and Validation of the Harvard Trauma Questionnaire (HTQ) and PTSD Checklist-5 (PCL-5) with Indian Women from Slums Reporting Gender-Based Violence (2021) (0)
Does intimate partner violence influence treatment effects on depression? Findings from a randomized controlled trial for a culturally-adapted behavioral activation treatment in Goa, India. (2020) (0)
Two Peas in a Pod? Understanding Cross-Cultural Similarities and Differences in Anxiety Disorders (2019) (0)
The Identification and management of vascular diseases and their risk factors in eight Indigenous primary health care services--The results of the Kanyini Vascular Collaboration Audit study (2008) (0)
Type 2 Diabetes Mellitus Resting Heart Rate and the Risk of Microvascular Complications in Patients With Copyright (2012) (0)
Importance of total or absolute CV risk (2006) (0)
What trials are required for the polypill? Clinical Trials Symposium (2007) (0)
Cardiovascular risk management in Australian general practice (2007) (0)
Progressing polypills beyond concepts to outcomes (2019) (0)
The real deal on tight glucose control. Plenary lecture (2008) (0)
P5319Evidence-practice gaps in the screening and management of cardiovascular risk factors in the Australian General Practice population (2019) (0)
[Plenary] ADVANCE – results of the blood pressure arm (2007) (0)
Observational studies, clinical trials and the media (2003) (0)
68 SYSTOLIC BLOOD PRESSURE VARIABILITY PREDICTS BOTH MACROVASCULAR AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES: THE ADVANCE TRIAL (2012) (0)
[Keynote lecture] Diabetes in the Diaspora: a global perspective (2008) (0)
anatomy and enhancing dynamic spatial orientation dur- ing transducer manipulation. (2011) (0)
Is the definition of the metabolic syndrome too simplistic (2007) (0)
(Plenary speaker) Cardiovascular disease prevention – Should we intervene earlier? (2012) (0)
A Hospital Quality Improvement Initiative for Patients with Acute Coronary Syndromes in China: A Cluster Randomised Controlled Trial (2011) (0)
Assessment of absolute risk (symposium) (2004) (0)
Clinical Trials in Asia – Crouching Tiger, Hidden Dragon (keynote plenary – Curtis Meinert Lecture) (2011) (0)
The experience of patients admitted with acute coronary syndromes (ACS) to hospitals in China (2007) (0)
Nutrition – a cardiovascular perspective (Symposium sponsored by the Macular Degeneration Foundation) (2011) (0)
1P-0271 Determinants of carotid intima-media thickness and plaque occurrence in type 2 diabetes (2003) (0)
Effects of intensive glucose control in diabetes – ADVANCE (Symposium) (2010) (0)
Tools to assess quality of life in adults with chronic conditions in India: A scoping review (2022) (0)
ADVANCE: Blood Pressure Lowering in Diabetes (2009) (0)
443 ANZACT, the Evolution of a Clinical Trial Network (2020) (0)
New diagnostic tests for acute cardiac disease (2005) (0)
HealthTracker Decision Support for Primary Care Practitioners: Development and Validation Testing (2011) (0)
Managing diabetes and associated risk factors for ischemic heart disease (Clinical Seminar) [Invited speaker] (2012) (0)
RESTING HEART RATE AND THE RISK OF DEATH AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: 7E.03 (2011) (0)
Cardiovascular risk prediction – population differences. Symposium on Risk Prediction (2006) (0)
PW120 Does obesity increase risk in the patient with an ACS (2014) (0)
The metabolic syndrome in Asia – is a single definition useful? (Symposium) (2004) (0)
Coronary risk factor reduction – hypertension control or blood pressure reduction? (2005) (0)
Six-month adherence to Statin use and subsequent risk of major adverse cardiovascular events (MACE) in patients discharged with acute coronary syndromes (2017) (0)
Concise review: the polypill in cardiovascular disease prevention (2007) (0)
Level and Treatment of Coronary Heart Disease Risk in A Rural Indian Population (2007) (0)
PO171 Barriers to the Use of Cardiovascular Polypills In India: A Mixed-Methods Study (2018) (0)
Can NT-proBNP monitoring help prevent cardiovascular disease? Recent Advances in Cardiovascular Disease (2007) (0)
[Plenary] Results of the glucose lowering arm of ADVANCE (2008) (0)
Strengthening health systems to improve control of common serious diseases and injuries. Chair (2008) (0)
The cardiovascular protective effects of statins are due mainly to non-lipid effects (Debate - Against) (2005) (0)
DWP3-A Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region (2008) (0)
The experience of patients with acute coronary syndromes admitted to hospitals in China (2007) (0)
Abstract 12172: HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
Abstract 13354: Effectiveness of a Complex Intervention Based on Electronic Decision Support to Improve Management of Cardiovascular Disease Risk in Primary Healthcare: A Cluster-randomised Controlled Trial (2020) (0)
Statistical Analysis Plan for the Lifestyle InterVention IN Gestational Diabetes (LIVING) trial (0)
PT253 Understanding the impact of a multifaceted quality improvement intervention to improve cardiovascular disease risk management in Australian Primary Health Care: The TORPEDO study process evaluation (2014) (0)
Lifestyle factors, addictions and cardiovascular risk: lessons from InterHEART (workshop) (2007) (0)
The George Centre for Healthcare Innovation (Discipline of Medicine workshop). (2011) (0)
ADVANCE: blood pressure lowering and intensive glucose control in type 2 diabetes (2001) (0)
Strengthening cardiovascular trials across Australia and New Zealand-the Alliance for Cardiovascular Trials (ANZACT) Network. (2021) (0)
Perindopril plus indapamide reduced death and major macrovascular and microvascular events in type 2 diabetes (2008) (0)
cardiovascular disease acceptability of a polypill for prevention of Process evaluation of the impact and and (2015) (0)
Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia (2023) (0)
Event rates in trials of patients with type 2 diabetes. (2010) (0)
Update on ADVANCE and a proposal for an international glucose lowering trialists’ collaboration (plenary) (2007) (0)
ADVANCE – results of the blood pressure lowering arm (2007) (0)
Transfer or tailor? Implementing a technology‐supported intervention for non‐communicable diseases across contexts (2022) (0)
Serum lipid levels in urban and rural population and the prevalence of dyslipidaemia in Thailand – are the NCEP III guidelines appropriate? (2005) (0)
Potential health gain at global level through effective risk factor control (2006) (0)
PREDICTING BLEEDING IN AN ACS POPULATION (2013) (0)
How to Treat – Cardiovascular Disease Risk Assessment (2009) (0)
The Influence of Exercise on Vascular Complications and Mortality Ii Patients with Type 2 Diabetes Mellitus (2012) (0)
Polypill in the prevention of cardiovascular disease: rationale and clinical data (2012) (0)
Research in low-resources settings (2012) (0)
Effects of blood pressure lowering on incidence and progression of retinopathy in patients with type 2 diabetes mellitus (2008) (0)
PS-BPC07-7: REDUCED EFFICACY OF BLOOD PRESSURE LOWERING DRUGS IN THE PRESENCE OF DIABETES MELLITUS: RESULTS FROM THE TRIUMPH RANDOMISED CONTROLLED TRIAL. (2023) (0)
Diabetes and Vascular Disease: A New International Trial (2003) (0)
Why do strategies to strengthen primary health care succeed in some places and fail in others? Exploring local variation in the effectiveness of a community health worker managed digital health intervention in rural India (2021) (0)
For peer review only INterpreting the Processes of the UMPIRE Trial (INPUT): the design of a process evaluation of a fixed dose combination (FDC) strategy to improve adherence to cardiovascular medications (2012) (0)
The role of beta blockers in cardiovascular therapeutics in 2008 – the evidence for hypertension (2008) (0)
Applying systems thinking to identify enablers and challenges to scale-up interventions for hypertension and diabetes in low-income and middle-income countries: protocol for a longitudinal mixed-methods study (2022) (0)
HDL Cholesterol and the Risk of Microvascular Disease of Type 2 Diabetes (2012) (0)
The Predictors of Discharge Without Clopidogrel Following Admission with Acute Coronary Syndrome in Australia – The CONCORDANCE Registry (2013) (0)
Effect of a multifaceted mobile technology enabled primary care intervention on cardiovascular disease risk management in rural Indonesia: a quasi-experimental study (2019) (0)
Progress in Medicine : Experts Take Stock The PLOSMedicine (2015) (0)
Effects of Fibrates in Chronic Kidney Disease across studies (2012) (0)
Evaluation of the First 12 Months of a Cardiovascular Disease (CVD) Risk Assessment and Treatment Program at Tāmaki Healthcare Primary Health Organisation, Auckland, New Zealand (2008) (0)
Early Bird Lecture – What do clinicians need to know about cardiovascular risk? Plenary (2005) (0)
The predictors of discharge without clopidogrel following admission with acute coronary syndrome in australia - the concordance registry (2013) (0)
Determinants of diabetes mellitus and cardiovascular diseases in the Asia Pacific region (2008) (0)
ACE inhibitors and blood pressure lowering in diabetes (2001) (0)
Implications of rising incidence of diabetes in the Asia Pacific region (2003) (0)

This paper list is powered by the following services:

Other Resources About Anushka Patel

en.wikipedia.org

What Schools Are Affiliated With Anushka Patel?

Anushka Patel is affiliated with the following schools: